FindTrial
Sign In

Evaluation of Selective Laser Trabeculoplasty for Intraocular Pressure Lowering in Chinese Eyes - A pilot study

Evaluation of Selective Laser Trabeculoplasty for Intraocular Pressure Lowering in Chinese Eyes - A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-09000731
Enrollment
Unknown
Registered
2009-07-27
Start date
2009-07-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma and ocular hypertension

Interventions

1:selective laser trabeculoplasty 15 minutes

Sponsors

NIL
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -A diagnosis of normal tension glaucoma, primary open angle glaucoma, primary angle closure glaucoma or steroid induced ocular hypertension / glaucoma; -Older than 18 years of age; -Able to give informed consent.

Exclusion criteria

Exclusion criteria: - Significant cataract rendering visual field testing or optic disc imaging not technically possible; - Previous SLT or ALT; - Participation in another therapeutic drug study within the last 30 days; - Severe health problems precluding follow-up such as end-stage heart disease, kidney disease, respiratory disease, or cancer.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure at 1 week, 1 month, 3 months, 6 months, 1 year;—

Secondary

MeasureTime frame
Visual field progression and Retinal nerve fiber layer progression at 1 year;—

Countries

China

Contacts

Public ContactDr. Leung Kai Shun Christopher
cksleung@cuhk.edu.hk+852 2762 3080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026